Virtual Screening for SARS-CoV Protease Based on KZ7088 Pharmacophore Points

Oba Y., 2003, New Engl. J. Med., 348, 2034, 10.1056/NEJM200305153482017

Anthrax, 2002, http://www.chem.ox.ac.uk/anthrax/results.htm

Richards W. G, 2002, Nature Rev. Drug Discovery, 1, 551, 10.1038/nrd841

Ajay A., 1998, J. Med. Chem., 41, 3314, 10.1021/jm970666c

Rishton G. M, 2003, Drug Discovery Today, 8, 86, 10.1016/S1359644602025722

Sadowski J., 1998, J. Med. Chem., 41, 3325, 10.1021/jm9706776

Lipinski C. A, 2000, J. Pharmacol. Toxicol. Methods, 44, 235, 10.1016/S1056-8719(00)00107-6

Xu J., 2000, J. Chem. Inf. Comput. Sci., 40, 1177, 10.1021/ci000026+

Oprea T. I, 2000, J. Comput.-Aided Mol. Des., 14, 251, 10.1023/A:1008130001697

Rishton G. M, 1997, Drug Discovery Today, 2, 382, 10.1016/S1359-6446(97)01083-0

Baurin N., 2002, Criblage virtuel et Analyse de chmiothèque, Université d'Orléans

Anand K., 2003, Science, 300, 1763, 10.1126/science.1085658

Chou K. C., 2003, Biochem. Biophys. Res. Comm., 308, 148, 10.1016/S0006-291X(03)01342-1

Wildman S. A., 1999, J. Chem. Inf. Comput. Sci., 39, 868, 10.1021/ci990307l

Group, C. C. MOE, H3A 2R7, Montreal, Canada. 2002.

WDI, World Drug Index

Chou J. J., 1998, Cell, 94, 171, 10.1016/S0092-8674(00)81417-8

Chou J. J., 1999, Cell, 96, 615, 10.1016/S0092-8674(00)80572-3

Chou J. J., 2001, Nature Struct. Biol., 8, 990, 10.1038/nsb1101-990

Chou K. C, 1995, FEBS Lett., 363, 123, 10.1016/0014-5793(95)00240-A

Chou K. C., 1999, Biochem. Biophys. Res. Commun., 259, 420, 10.1006/bbrc.1999.0792

Chou K. C., 2000, FEBS Lett., 470, 249, 10.1016/S0014-5793(00)01333-8

Chou K. C., 2002, Biochem. Biophys. Res. Commun., 292, 702, 10.1006/bbrc.2002.6686